JP2024074963A5 - - Google Patents

Download PDF

Info

Publication number
JP2024074963A5
JP2024074963A5 JP2024062811A JP2024062811A JP2024074963A5 JP 2024074963 A5 JP2024074963 A5 JP 2024074963A5 JP 2024062811 A JP2024062811 A JP 2024062811A JP 2024062811 A JP2024062811 A JP 2024062811A JP 2024074963 A5 JP2024074963 A5 JP 2024074963A5
Authority
JP
Japan
Prior art keywords
tradipitant
pharmaceutical composition
administered
composition according
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2024062811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024074963A (ja
Filing date
Publication date
Priority claimed from JP2021012356A external-priority patent/JP2021073258A/ja
Application filed filed Critical
Publication of JP2024074963A publication Critical patent/JP2024074963A/ja
Publication of JP2024074963A5 publication Critical patent/JP2024074963A5/ja
Withdrawn legal-status Critical Current

Links

JP2024062811A 2015-03-04 2024-04-09 トラジピタントによる治療方法 Withdrawn JP2024074963A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562128472P 2015-03-04 2015-03-04
US62/128,472 2015-03-04
US201562232644P 2015-09-25 2015-09-25
US62/232,644 2015-09-25
JP2021012356A JP2021073258A (ja) 2015-03-04 2021-01-28 トラジピタントによる治療方法
JP2023006082A JP2023052486A (ja) 2015-03-04 2023-01-18 トラジピタントによる治療方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023006082A Division JP2023052486A (ja) 2015-03-04 2023-01-18 トラジピタントによる治療方法

Publications (2)

Publication Number Publication Date
JP2024074963A JP2024074963A (ja) 2024-05-31
JP2024074963A5 true JP2024074963A5 (https=) 2024-07-29

Family

ID=55629110

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017546704A Active JP6891385B2 (ja) 2015-03-04 2016-03-04 トラジピタントによる治療方法
JP2021012356A Pending JP2021073258A (ja) 2015-03-04 2021-01-28 トラジピタントによる治療方法
JP2023006082A Pending JP2023052486A (ja) 2015-03-04 2023-01-18 トラジピタントによる治療方法
JP2024062811A Withdrawn JP2024074963A (ja) 2015-03-04 2024-04-09 トラジピタントによる治療方法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2017546704A Active JP6891385B2 (ja) 2015-03-04 2016-03-04 トラジピタントによる治療方法
JP2021012356A Pending JP2021073258A (ja) 2015-03-04 2021-01-28 トラジピタントによる治療方法
JP2023006082A Pending JP2023052486A (ja) 2015-03-04 2023-01-18 トラジピタントによる治療方法

Country Status (19)

Country Link
US (6) US10463655B2 (https=)
EP (2) EP3730140A1 (https=)
JP (4) JP6891385B2 (https=)
KR (3) KR20170122777A (https=)
CN (2) CN107427502B (https=)
AU (4) AU2016226006B2 (https=)
BR (1) BR112017018620A2 (https=)
CA (2) CA2978736C (https=)
CL (1) CL2017002238A1 (https=)
DK (1) DK3265087T3 (https=)
ES (1) ES2824552T3 (https=)
HR (1) HRP20201627T1 (https=)
HU (1) HUE050944T2 (https=)
IL (1) IL254142B (https=)
MX (2) MX385788B (https=)
PT (1) PT3265087T (https=)
RU (1) RU2770050C2 (https=)
WO (1) WO2016141341A1 (https=)
ZA (1) ZA201706059B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2978736C (en) * 2015-03-04 2023-11-07 Vanda Pharmaceuticals Inc. Dosing regimen of tradipitant
CA3073998A1 (en) * 2017-09-13 2019-03-21 Vanda Pharmaceuticals Inc. Improved treatment of atopic dermatitis with tradipitant
KR20250140655A (ko) * 2017-11-17 2025-09-25 반다 파마슈티칼즈, 인코퍼레이티드. 트라디피탄트를 이용한 위장 질환의 치료 방법
CN112218636B (zh) * 2018-06-08 2025-05-06 万达制药公司 使用川地匹坦进行治疗的方法
US10821099B2 (en) 2018-09-28 2020-11-03 Vanda Pharmaceuticals Inc. Use of tradipitant in motion sickness
KR102863233B1 (ko) * 2018-09-28 2025-09-22 반다 파마슈티칼즈, 인코퍼레이티드. 멀미에서의 트라디피탄트의 용도
WO2020117811A1 (en) 2018-12-03 2020-06-11 Vanda Pharmaceuticals Inc. Method of treatment with tradipitant
WO2020132513A1 (en) 2018-12-21 2020-06-25 Vanda Pharmaceuticals Inc. Improved treatment of atopic dermatitis with tradipitant
JP2023515167A (ja) * 2020-02-25 2023-04-12 バンダ・ファーマシューティカルズ・インコーポレイテッド トラジピタントによるアトピー性皮膚炎の改善された治療
WO2021195205A1 (en) 2020-03-26 2021-09-30 Vanda Pharmaceuticals Inc. Treatment of lower respiratory tract infection with tradipitant
WO2023019084A1 (en) 2021-08-12 2023-02-16 Vanda Pharmaceuticals Inc. Treatment of gastric accommodation with tradipitant
US20240350469A1 (en) 2021-08-31 2024-10-24 Vanda Pharmaceuticals Inc. Treatment of lower respiratory tract infection with tradipitant
CN120641099A (zh) 2022-12-21 2025-09-12 万达制药公司 使用曲地匹坦的治疗方法
EP4599831A1 (en) 2024-02-09 2025-08-13 Vanda Pharmaceuticals Inc. Treatment of gastroparesis with tradipitant

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305718D0 (en) 1993-03-19 1993-05-05 Glaxo Group Ltd Medicaments
TW263498B (https=) 1993-11-10 1995-11-21 Takeda Pharm Industry Co Ltd
GB9513972D0 (en) 1995-07-08 1995-09-06 Merck Sharp & Dohme Pharmaceutical compositions
EP1394150B1 (en) 1999-02-24 2011-01-19 F. Hoffmann-La Roche AG 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
US6849624B2 (en) * 2001-07-31 2005-02-01 Hoffmann-La Roche Inc. Aromatic and heteroaromatic substituted amides
KR100755577B1 (ko) * 2002-04-26 2007-09-12 일라이 릴리 앤드 캄파니 타키키닌 수용체 길항제로서의 트리아졸 유도체
BR0309486A (pt) 2002-04-26 2005-02-09 Lilly Co Eli Composto ou um seu sal farmaceuticamente aceitável, composição farmacêutica, e, método para o tratamento de uma condição associada com um excesso de taquicininas
JP2004250329A (ja) 2002-12-26 2004-09-09 Dainippon Pharmaceut Co Ltd イサチン誘導体
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
NZ580480A (en) * 2003-10-24 2010-02-26 Lilly Co Eli Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
JP4673068B2 (ja) 2005-01-19 2011-04-20 独立行政法人科学技術振興機構 Ｔｈ１型アレルギー疾患治療用組成物
DE102005006217B4 (de) 2005-02-07 2007-08-16 Universitätsklinikum Hamburg-Eppendorf Diagnose von allergischen Erkrankungen und/oder atopischen Erkrankungen durch Nachweis von Autoantikörpern gegen CD28 in humanem Serum
WO2007096782A2 (en) 2006-02-22 2007-08-30 Valorisation Recherche Hscm, Limited Partnership Compositions for disorders associated wtth metachromatic cell activation
CN101568523A (zh) 2006-12-20 2009-10-28 伊莱利利公司 用于制备{2-[1-(3,5-二-三氟甲基-苄基)-5-吡啶-4-基-1h-[1,2,3]三唑-4-基]－吡啶－3－基｝·(2－氯苯基)甲酮的新中间体和方法
CN102573475B (zh) 2009-08-14 2016-01-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂
PT2722045T (pt) 2009-11-18 2016-10-18 Helsinn Healthcare Sa Composições para o tratamento de náuseas e vómitos mediadas centralmente
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
WO2014093907A1 (en) 2012-12-13 2014-06-19 A.P. Pharma, Inc. Pharmaceutical composition comprising antiemetic compounds and polyorthoester
JP6644328B2 (ja) 2013-02-28 2020-02-12 ロート製薬株式会社 アトピー性疾患の発症又は重症化リスクの評価法
US8906951B1 (en) * 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
BR112015031724A2 (pt) * 2013-06-24 2017-07-25 Tigercat Pharma Inc uso do antagonista do receptor nk-1 serlopitant em pruridos
CA2978736C (en) * 2015-03-04 2023-11-07 Vanda Pharmaceuticals Inc. Dosing regimen of tradipitant
WO2016195723A1 (en) 2015-06-03 2016-12-08 Beller Pharmaceuticals LLC Methods of treatment for conditions mediated by substance p
WO2017060488A1 (en) 2015-10-09 2017-04-13 Almirall, S.A. New trpa1 antagonists
EP3383363B1 (en) 2015-11-30 2021-01-06 Anacor Pharmaceuticals, Inc. Topical pharmaceutical formulations for treating inflammatory-related conditions
WO2017112792A1 (en) 2015-12-22 2017-06-29 Takeda Pharmaceutical Company Limited Tripartite modulators of endosomal g protein-coupled receptors
CA3073998A1 (en) 2017-09-13 2019-03-21 Vanda Pharmaceuticals Inc. Improved treatment of atopic dermatitis with tradipitant
KR20250140655A (ko) * 2017-11-17 2025-09-25 반다 파마슈티칼즈, 인코퍼레이티드. 트라디피탄트를 이용한 위장 질환의 치료 방법
CN112218636B (zh) * 2018-06-08 2025-05-06 万达制药公司 使用川地匹坦进行治疗的方法
KR102863233B1 (ko) * 2018-09-28 2025-09-22 반다 파마슈티칼즈, 인코퍼레이티드. 멀미에서의 트라디피탄트의 용도
US10821099B2 (en) 2018-09-28 2020-11-03 Vanda Pharmaceuticals Inc. Use of tradipitant in motion sickness
WO2020117811A1 (en) * 2018-12-03 2020-06-11 Vanda Pharmaceuticals Inc. Method of treatment with tradipitant

Similar Documents

Publication Publication Date Title
JP2024074963A5 (https=)
JP2018507243A5 (https=)
RU2707089C2 (ru) Комбинированная композиция
KR20080059208A (ko) 수면 호흡 장애를 예방 및 치료하는 방법과 그 수단
RU2010109359A (ru) Азитромицин для лечения кожных заболеваний
AU2014299447B2 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
US20260069543A1 (en) Controlled-release tablet of ibuprofen and its use for relieving pain
JP2010538066A5 (https=)
RU2007101686A (ru) Комбинированная композиция
CN104039148A (zh) 组合als疗法
JP2022177119A5 (https=)
JP2021530568A5 (https=)
JPWO2022107125A5 (https=)
JP2024507264A (ja) メラトニンを含む多層ペレットの製剤
TW201806599A (zh) 用於快速開始抗抑鬱作用之給藥方案
RU2002115814A (ru) Лечение системной красной волчанки с помощью дегидроэпиандростерона
JP2001139469A (ja) 新しい徐放性薬剤複合体
UA128573C2 (uk) Способи лікування підвищення маси тіла, індукованого антипсихотичними засобами, за допомогою мірикориланту
Post Treatment of cluster headache symptoms using synthetic tryptamine N, N-diallyl-5 methoxytryptamine
TWI744858B (zh) 治療精神疾病之控釋藥物組合物和方法
CN109381458B (zh) 甲吡唑及其盐在制备抗癫痫药物中的用途
US20230028539A1 (en) Pharmaceutical composition, complementary kit and application thereof
JPWO2020018291A5 (https=)
US10265300B2 (en) Methods of treating seizure disorders
EP4267132A1 (en) Celecoxib for treating pain